Company intelligence / Profile preview

Embolitech

United States

Ownership: Private
Development stage: Other

Overview

The mechanical thrombectomy device developed by Embolitech (now commercialized by Surmodics as the Pounce Thrombectomy System) has shown positive outcomes in clinical use, effectively removing arterial thrombi/peripheral emboli and restoring blood flow without the use of thrombolytics[2].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Surmodics (acquirer and commercial partner)

Beyond the preview

Go deeper on Embolitech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Embolitech.

Explore the full profile